Jianerkang Medical Co., Ltd. (SHA:603205)

Jianerkang Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	642.74	721.81	226.24	178.25	97.8	94.69
Cash & Short-Term Investments	747.87	721.81	226.24	178.25	97.8	94.69
Cash Growth	319.56%	219.05%	26.92%	82.27%	3.28%	-30.22%
Accounts Receivable	199.63	212.32	235.5	189.16	138.75	127.94
Other Receivables	8.12	14.4	9.04	4.43	6.96	12.36
Receivables	207.75	226.72	244.54	193.59	145.71	140.3
Inventory	173.51	176.3	158.41	170.44	158.62	170.69
Prepaid Expenses	-	-	0.52	9.01	0.09	1.41
Other Current Assets	11.03	10.32	11.07	20.71	8.39	4.88
Total Current Assets	1,140	1,135	640.78	572.01	410.6	411.98
Property, Plant & Equipment	360.14	365.42	383.67	356.1	326.67	305.16
Other Intangible Assets	58.1	58.41	59.92	61.39	63.19	65.03
Long-Term Deferred Tax Assets	23.04	23.02	23.12	25.96	24.37	22.42
Long-Term Deferred Charges	10.34	6.6	3.02	2.09	2.07	1.38
Other Long-Term Assets	4.44	1.97	3.06	10.93	13.52	17.29
Total Assets	1,596	1,591	1,114	1,028	840.43	823.27
Accounts Payable	98.16	87.33	103.14	95.25	73.14	144.92
Accrued Expenses	-	27.74	34.07	42.3	31.45	29.17
Short-Term Debt	-	-	-	30.04	50.05	69.55
Current Income Taxes Payable	5.97	3.44	7.78	4.77	1.43	24.24
Current Unearned Revenue	5.27	6.48	4.32	8.85	4.59	30.02
Other Current Liabilities	1.53	9.74	16.47	21.98	14.76	0.56
Total Current Liabilities	110.93	134.74	165.79	203.19	175.42	298.46
Long-Term Unearned Revenue	33.78	34.64	38.24	41.8	47.76	47.7
Long-Term Deferred Tax Liabilities	1.16	1.06	0.19	0.19	0.2	0.21
Total Liabilities	145.86	170.43	204.22	245.18	223.39	346.37
Common Stock	120	120	90	90	90	90
Additional Paid-In Capital	712.11	710.69	350.13	347.62	338.7	330.18
Retained Earnings	618.25	589.44	469.22	345.68	188.34	56.71
Comprehensive Income & Other	-0	-0	-	-	-	-
Shareholders' Equity	1,450	1,420	909.35	783.29	617.04	476.9
Total Liabilities & Equity	1,596	1,591	1,114	1,028	840.43	823.27
Total Debt	-	-	-	30.04	50.05	69.55
Net Cash (Debt)	747.87	721.81	226.24	148.21	47.75	25.13
Net Cash Growth	404.62%	219.05%	52.65%	210.40%	89.99%	-
Net Cash Per Share	7.30	7.63	2.51	1.65	0.53	0.31
Filing Date Shares Outstanding	120	120	90	90	90	80.05
Total Common Shares Outstanding	120	120	90	90	90	80.05
Working Capital	1,029	1,000	474.99	368.82	235.18	113.51
Book Value Per Share	12.09	11.83	10.10	8.70	6.86	5.96
Tangible Book Value	1,392	1,362	849.43	721.91	553.85	411.87
Tangible Book Value Per Share	11.60	11.35	9.44	8.02	6.15	5.14
Buildings	-	295.48	294.63	241.34	233.68	184.41
Machinery	-	346.13	321.4	303.54	259.27	240.75
Construction In Progress	-	4.97	11.9	17.36	7.33	24.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.